O
ptic neuritis (ON) refers to inflammation within the optic nerve, which may occur as an isolated event or in association with multiple sclerosis (MS). [1] [2] [3] [4] ON is common, with an incidence of 1-5 per 100,000 per year. 1 Much of our understanding regarding the clinical presentation of ON has come from the Optic Neuritis Treatment Trial (ONTT) 2 and the findings of the Optic Neuritis Study Group. 4 ONTT compared the effects of oral prednisone versus high-dose intravenous methylprednisolone with placebo on visual outcome among patients with ON. In this study, most patients were white (85%) and female (77%), with a mean age of 32 years. 2, 4 Common presenting symptoms of ON include [1] [2] [3] [4] [5] • Subacute reduction of visual acuity (usually monocular) • Orbital pain exacerbated by eye movements • Dyschromatopsia (loss of color vision) • Photopsias • A relative afferent pupil defect • A normal-appearing optic nerve or mild optic disc swelling
The pain associated with ON tends to progress over days. Vision typically improves over 3-8 weeks, and most visual recovery occurs within the first 6 months but can continue for up to 1 year after the acute event. [1] [2] [3] 6 However, many patients may experience variable visual complaints and dysfunction after recovery. 
Differential Diagnosis
A progressive clinical course or the observation of optic disc pallor at the time of presentation may indicate an underlying compressive lesion, such as a nerve sheath tumor or suprasellar mass, which would warrant cranial and/or orbital imaging. In some cases, the patient may report subacute-onset awareness of vision loss, when in fact the visual dysfunction has been more insidious over time and is caused by a compressive lesion. Abundant vitreous cell or florid optic disc edema at the time of presentation may indicate a diagnosis of neuroretinitis. 1 Careful clinical follow-up may disclose the development of a macular star over time. 1 In such cases, the imaging surveillance and further investigations for MS are not indicated.
Older individuals with vascular risk factors may present with pain and vision loss resulting from anterior ischemic optic neuropathy. In such cases, the diagnosis is often apparent because of the clinical history, visible optic disc swelling at presentation, and failure to improve over time. 7 In addition, these patients often have a specific morphological appearance, with a small or absent physiological cup to suggest the diagnosis. 1 Posterior ischemic optic neuropathy cases may be more challenging to distinguish from ON because optic disc swelling is not apparent. Again, a compatible clinical history and course should suggest this diagnosis, which is one of exclusion. Perioptic neuritis, also known as perineuritis, is a variant of orbital pseudotumor and may be distinguished from ON on both clinical and radiological grounds. Patients tend to be older, have spared central vision, and show marked steroid responsiveness. 8, 9 The orbital magnetic resonance imaging (MRI) scan demonstrates perineural inflammation, in lieu of the intrinsic optic nerve inflammation seen in ON. 8, 9 In Devic's neuromyelitis optica, classically bilateral optic nerve inflammation appears with an otherwise normal MRI scan and poor visual recovery. 10 Diseases with ophthalmic manifestations may confuse the diagnosis. Selected differential diagnoses and their distinguishing features are described in Table 1 .
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Diagnostic Testing
Visual function
On examination, the fundus is normal because two-thirds of adult ON cases are retrobulbar ( Figure 1) . 2 Pupillary light reaction is decreased in the affected eye, and a relative afferent pupillary defect (RAPD) or Marcus Gunn pupil is often found.
1-3 Measurement of visual acuity reveals varying degrees of reduction in vision, from a mild decrease to complete vision loss.
1,2 Most patients with decreased visual acuity also have abnormal contrast sensitivity and color vision. 2 Visual field abnormalities tend to reflect involvement of the retinal nerve fiber layer and include altitudinal, arcuate, and cecocentral defects.
Laboratory studies
Typical cases of ON do not warrant extensive investigation. ONTT demonstrated low yield of ancillary tests, including chest radiography, and serological (antinuclear antibody [ANA] and syphilis) testing in unveiling alternate diagnoses in this context. 2 Various blood tests such as erythrocyte sedimentation rate, thyroid function tests, ANA, angiotensinconverting enzyme, and mitochondrial DNA mutation studies may be performed to exclude causes of optic neuropathy other than demyelinating ON. 1, 7 The presence of raised protein concentration, oligoclonal bands, and elevated immunoglobulins in the cerebrospinal fluid supports the diagnosis of MS as the cause of ON.
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Imaging studies
Advances in MRI techniques have improved our ability to visualize damage to the anterior visual axis. More specifically, orbital, fat-suppressed views of the orbits with gadolinium enhancement demonstrate the area of inflammation within the optic nerve, and these findings may persist for several weeks. 1, 12 However, the main role for cranial MRI studies is to identify the future risk of MS, because the presence of asymptomatic white matter lesions on the MRI scan is the strongest predictor for this diagnosis. 1, 3, 11, [13] [14] [15] 
Other tests
Visual evoked potentials (VEPs) are important in evaluating patients with suspected ON and frequently show a prolonged latency to the P100 response, with a relatively well preserved waveform. VEP abnormalities may be transitory, and this modality of testing may be used to detect subclinical ON events.
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Future Risk of MS
The presence of abnormalities on a baseline MRI scan is the strongest predictor for future clinically definite MS (CDMS) among ON patients. 1, 3, 11, [13] [14] [15] ONTT showed that for patients with three or more white matter lesions, the 5-year incidence of MS was >50%. 1, 13 In this study, lack of pain, mild optic disc swelling, and mild visual acuity loss were features associated with a lower risk of CDMS among patients with no brain lesions on the baseline MRI scan. 13 Twelve-year follow-up of patients in ONTT revealed that one or more lesions on MRI correlated with a 56% risk of CDMS, and no lesions correlated with a 22% risk. Features associated with a decreased risk of future CDMS included a normal MRI scan, no light-perception vision, prominent optic disc swelling, absence of pain, and being male.
14 Evaluation of neurological disability among patients in ONTT revealed that disability was unrelated to baseline scan and that vision loss contributed little to the Expanded Disability Status Scale (EDSS) score. 17 In a study of clinically isolated syndromes, which included ON and spinal cord and brain stem syndromes, CDMS later developed in 88% of patients with abnormal baseline MRI scans and 19% of patients with normal scans. Patients with worse clinical outcomes had more and larger MRI lesions at clinical presentation.
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Case Study
Optical imaging techniques such as optical coherence tomography (OCT) may be used to reliably quantify axon loss and provide a structural correlate to measures of visual function, as illustrated by the following case study.
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A 42-year-old woman presented with pain and subacuteonset vision loss in the right eye:
• Visual acuity measured count fingers in the right eye and 20/20 in the left eye.
• A right relative afferent pupil defect was found.
• Fundus examination showed mild optic disc swelling (hyperemia) in the right eye and normal findings in the left eye.
OCT revealed some initial thickening of the overall retinal nerve fiber layer thickness in the right eye at presentation, which reflected the hyperemia in this optic nerve (Figure 2) . After 6 months, marked thinning of the retinal nerve fiber layer was found, which represented permanent damage to the optic nerve, and the patient did not recover vision in this eye. The OCT measurements were unchanged in the left eye after 6 months. Permanent axon loss was the presumed substrate of irreversible visual dysfunction in the right eye. OCT measurements of retinal nerve fiber layer thickness have been found to be diminished among patients with MS and ON, and reduced OCT-measured retinal nerve fiber layer values have been correlated with impaired tests of visual function.
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Treatment
The treatment of ON has been dictated largely by the findings of ONTT, which demonstrated that patients treated with intravenous steroids had fewer repeat attacks of ON than those treated with oral steroids alone. 2, 3 Patients treated with oral prednisone alone had a higher risk of repeat attacks of ON than patients treated with placebo. 2, 3 Notably, post hoc analyses from ONTT showed that patients treated with intravenous steroids had a lower risk of CDMS at 2 years than patients treated with oral prednisone or placebo. [1] [2] [3] As a result of ONTT, clinicians typically treat patients with high-dose corticosteroid therapy in the acute phase of ON, with or without an oral steroid taper. The American Academy of Neurology has advised that oral prednisone (1 mg/kg) is not appropriate treatment for ON. 22 Patients may be treated with 3-5 days of intravenous corticosteroids followed by 10-14 days of oral steroids, at the discretion of the treating physician.
Conclusions
ON is often the first demyelinating event experienced by patients with MS. Numerous conditions mimic ON, so a careful history and thorough examination are critical. The neuro-ophthalmic exam may predict future risk of MS. New optical imaging techniques such as OCT may have a potential role as a structural biomarker for axon loss in the optic nerve.
Results of large-scale trials suggest that not only is ON a predictor of MS, but early treatment can postpone onset of the disease.
